Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Lilly_USA
gptkb:Lilly_ICOS |
| gptkbp:ceo |
gptkb:David_A._Ricks
|
| gptkbp:employees |
over 38,000
|
| gptkbp:founded |
1876
|
| gptkbp:founder |
gptkb:Eli_Lilly
|
| gptkbp:headquarters |
gptkb:Indianapolis,_Indiana
|
| https://www.w3.org/2000/01/rdf-schema#label |
LLY
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:partnership |
gptkb:Boehringer_Ingelheim
gptkb:Pfizer |
| gptkbp:products |
gptkb:diabetes
Antidepressants Cancer medications |
| gptkbp:research_focus |
gptkb:diabetes
gptkb:Oncology Immunology Neuroscience |
| gptkbp:revenue |
$28.5 billion (2022)
|
| gptkbp:stock_symbol |
gptkb:LLY
|
| gptkbp:subsidiary |
gptkb:Im_Clone_Systems
|
| gptkbp:website |
www.lilly.com
|
| gptkbp:bfsParent |
gptkb:Eli_Lilly
|
| gptkbp:bfsLayer |
4
|